Declaration

February 18, 2022   |   Growth Equity News Healthcare

Synthego raises $200 million to accelerate the field of CRISPR-based medicines from early-phase research to the clinic

https://www.declarationpartners.com/wp-content/uploads/2022/02/Screenshot-2022-02-16-at-19.39.36.png

Declaration is proud to support Synthego Corporation advance its cutting-edge genome engineering platform, which accelerates the field of CRISPR-based innovation from early-phase research through the clinic.

 

https://www.prnewswire.com/news-releases/synthego-raises-200-million-to-accelerate-the-field-of-crispr-based-medicines-from-early-phase-research-to-the-clinic-301484417.html